Roth Capital initiated coverage on shares of BioRestorative Therapies (OTCMKTS:BRTX – Get Rating) in a research report sent to investors on Wednesday, The Fly reports. The firm issued a buy rating and a $15.00 price target on the stock.
Separately, Maxim Group initiated coverage on BioRestorative Therapies in a report on Wednesday, September 28th. They issued a buy rating on the stock.
Get BioRestorative Therapies alerts:BioRestorative Therapies Price Performance
OTCMKTS BRTX opened at $3.16 on Wednesday. BioRestorative Therapies has a 1-year low of $2.46 and a 1-year high of $6.25. The business's fifty day moving average price is $3.16 and its 200-day moving average price is $3.27.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in BioRestorative Therapies stock. Cambridge Investment Research Advisors Inc. bought a new position in BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Rating) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 23,001 shares of the company's stock, valued at approximately $120,000. Cambridge Investment Research Advisors Inc. owned 0.63% of BioRestorative Therapies as of its most recent filing with the SEC. Institutional investors own 31.66% of the company's stock.BioRestorative Therapies Company Profile
(Get Rating)
BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.
Further Reading
- Get a free copy of the StockNews.com research report on BioRestorative Therapies (BRTX)
- MarketBeat: Week in Review 12/05 – 12/09
- There Is Fundamental Value In Broadcom, And It Yields 3.35%
- Costco vs Amazon: an end of the year showdown
- Discount Retailers Could Make Good Bargain Stocks
- Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.